Pacific Biosciences Of California (PACB) Net Equity Issued and Repurchased (2010 - 2023)
Pacific Biosciences Of California (PACB) posted quarterly Net Equity Issued and Repurchased of $189.2 million for Q1 2023, up 11128.49% quarter-over-quarter from $1.7 million in Q4 2021.
Pacific Biosciences Of California (PACB) Net Equity Issued and Repurchased (2010 - 2023) Analysis & Trends
Pacific Biosciences Of California's Net Equity Issued and Repurchased history runs 13 years deep, the most recent figure standing at $189.2 million for Q1 2023.
- In Q1 2023, Net Equity Issued and Repurchased changed N/A year-over-year to $189.2 million; the TTM figure through Dec 2023 stood at $189.2 million (changed N/A YoY), while the FY2023 annual figure was $189.2 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased for Q1 2023 stood at $189.2 million, up from $1.7 million in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $300.0 million in Q3 2021, with the low at $131000.0 in Q4 2019.
- The 4-year median for Net Equity Issued and Repurchased is $3.0 million (2021), against an average of $43.9 million.
- The sharpest annual moves came in 2019 and 2020: Net Equity Issued and Repurchased plunged 97.61% in 2019, then soared 24469.47% in 2020.
- Pacific Biosciences Of California's Net Equity Issued and Repurchased stood at $131000.0 in 2019, then jumped by 24469.47% to $32.2 million in 2020, then sank by 94.76% to $1.7 million in 2021, then jumped by 11128.49% to $189.2 million in 2023.
- Business Quant data shows PACB's Net Equity Issued and Repurchased at $189.2 million in Q1 2023, $1.7 million in Q4 2021, and $300.0 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | - |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | - |
| 10 | Pacific Biosciences Of California | 397.64 Mn | 160.77 Mn | 12.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 189.20 Mn |
| Mar 31, 2023 | 189.20 Mn |
| Dec 31, 2021 | 1.69 Mn |
| Dec 31, 2021 | 1.69 Mn |
| Sep 20, 2021 | 300.00 Mn |
| Sep 20, 2021 | 300.00 Mn |
| Jun 30, 2021 | 2.97 Mn |
| Jun 30, 2021 | 2.97 Mn |
| Mar 31, 2021 | 22.34 Mn |
| Mar 31, 2021 | 22.34 Mn |
| Dec 31, 2020 | 32.19 Mn |
| Dec 31, 2020 | 32.19 Mn |
| Sep 30, 2020 | 13.35 Mn |
| Sep 30, 2020 | 13.35 Mn |
| Jun 30, 2020 | 628,000.00 |
| Jun 30, 2020 | 628,000.00 |
| Mar 31, 2020 | 199,000.00 |
| Mar 31, 2020 | 199,000.00 |
| Dec 31, 2019 | 131,000.00 |
| Dec 31, 2019 | 131,000.00 |